Lipoprotein (a) concentrations as risk indicators for atherosclerosis
The plasma concentration of different lipoproteins were measured in 102 control children, in 42 children with a parent suffering from coronary heart disease (CHD), and in 50 children with a parent with cerebrovascular disease (CVD). Significant differences between controls and children in the other...
Gespeichert in:
Veröffentlicht in: | Archives of disease in childhood 1991-09, Vol.66 (9), p.1054-1056 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1056 |
---|---|
container_issue | 9 |
container_start_page | 1054 |
container_title | Archives of disease in childhood |
container_volume | 66 |
creator | Kostner, G M Czinner, A Pfeiffer, K H Bihari-Varga, M |
description | The plasma concentration of different lipoproteins were measured in 102 control children, in 42 children with a parent suffering from coronary heart disease (CHD), and in 50 children with a parent with cerebrovascular disease (CVD). Significant differences between controls and children in the other two groups were found for apolipoprotein A I, apolipoprotein B, and high density lipoprotein-cholesterol. Children of parents with CHD differed from controls in total cholesterol and apolipoprotein A II concentrations. A highly significant difference furthermore was found in lipoprotein (a) concentrations from children of parents with CHD in comparison with controls, but not between children of parents with CVD and controls. The difference in lipoprotein (a) concentrations (children of parents with CHD compared with controls) were only noticed in children above the age of 10 years. This could be explained by the observed rise of lipoprotein (a) between age 2 and 13 years, which was much more pronounced in the group with parents who had CHD. Plasma glycosaminoglycan concentrations were also measured in the three groups. They were significantly higher in children of parents with CHD and CVD compared with controls; they also varied with age. |
doi_str_mv | 10.1136/adc.66.9.1054 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1793056</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72164285</sourcerecordid><originalsourceid>FETCH-LOGICAL-b482t-9ef401994b1f8d445a046de2a99326fc649a3219f4b3e1a98e5bbc8d0fa213633</originalsourceid><addsrcrecordid>eNqFkEtP3DAUhS3Uig6UJctKWSA0LDL4FcfeIKEB2kojUMVjwca6cWwwZOLBzlTw78koo6GsuvD14nw699yD0D7BE0KYOIbaTISYqAnBBd9CI8KFzCnm_AsaYYxZrqSU39BOSk8YEyol20bbRFFVEDpC5zO_CIsYOuvbbAxHmQmtsW0XofOhTRmkLPr0nPm29ga6EFPmQsyge7QxJNOspk_f0VcHTbJ7638X3V6c30x_5bOrn7-np7O84pJ2ubKOY6IUr4iTNecFYC5qS0EpRoUzgitglCjHK2YJKGmLqjKyxg5ofypju-hk8F0sq7mth6CNXkQ_h_imA3j9WWn9o34IfzUpFcOF6A0O1wYxvCxt6vTcJ2ObBloblkmXlAhOZdGD-QCa_sAUrdssIVivetd971oIrfSq957_8W-yD3ooutcP1jokA42L0BqfNljBSyb6t1nrU2dfNzLEZy1KVhb68m6qxT0nZ3fXf_Rq7Xjgq_nTfxK-A9wGqCg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72164285</pqid></control><display><type>article</type><title>Lipoprotein (a) concentrations as risk indicators for atherosclerosis</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Kostner, G M ; Czinner, A ; Pfeiffer, K H ; Bihari-Varga, M</creator><creatorcontrib>Kostner, G M ; Czinner, A ; Pfeiffer, K H ; Bihari-Varga, M</creatorcontrib><description>The plasma concentration of different lipoproteins were measured in 102 control children, in 42 children with a parent suffering from coronary heart disease (CHD), and in 50 children with a parent with cerebrovascular disease (CVD). Significant differences between controls and children in the other two groups were found for apolipoprotein A I, apolipoprotein B, and high density lipoprotein-cholesterol. Children of parents with CHD differed from controls in total cholesterol and apolipoprotein A II concentrations. A highly significant difference furthermore was found in lipoprotein (a) concentrations from children of parents with CHD in comparison with controls, but not between children of parents with CVD and controls. The difference in lipoprotein (a) concentrations (children of parents with CHD compared with controls) were only noticed in children above the age of 10 years. This could be explained by the observed rise of lipoprotein (a) between age 2 and 13 years, which was much more pronounced in the group with parents who had CHD. Plasma glycosaminoglycan concentrations were also measured in the three groups. They were significantly higher in children of parents with CHD and CVD compared with controls; they also varied with age.</description><identifier>ISSN: 0003-9888</identifier><identifier>EISSN: 1468-2044</identifier><identifier>DOI: 10.1136/adc.66.9.1054</identifier><identifier>PMID: 1929512</identifier><identifier>CODEN: ADCHAK</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health</publisher><subject>Adolescent ; Age Factors ; Apolipoprotein A-I - analysis ; Apolipoprotein A-II - analysis ; Apolipoproteins - blood ; Apolipoproteins B - blood ; Arteriosclerosis - blood ; Arteriosclerosis - genetics ; Biological and medical sciences ; Cerebrovascular Disorders - blood ; Child ; Child, Preschool ; Cholesterol, HDL - blood ; Coronary Disease - blood ; Glycosaminoglycans - blood ; Humans ; Lipoproteins, HDL - blood ; Medical sciences ; Metabolic diseases ; Risk Factors</subject><ispartof>Archives of disease in childhood, 1991-09, Vol.66 (9), p.1054-1056</ispartof><rights>1992 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b482t-9ef401994b1f8d445a046de2a99326fc649a3219f4b3e1a98e5bbc8d0fa213633</citedby><cites>FETCH-LOGICAL-b482t-9ef401994b1f8d445a046de2a99326fc649a3219f4b3e1a98e5bbc8d0fa213633</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1793056/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1793056/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=5473647$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1929512$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kostner, G M</creatorcontrib><creatorcontrib>Czinner, A</creatorcontrib><creatorcontrib>Pfeiffer, K H</creatorcontrib><creatorcontrib>Bihari-Varga, M</creatorcontrib><title>Lipoprotein (a) concentrations as risk indicators for atherosclerosis</title><title>Archives of disease in childhood</title><addtitle>Arch Dis Child</addtitle><description>The plasma concentration of different lipoproteins were measured in 102 control children, in 42 children with a parent suffering from coronary heart disease (CHD), and in 50 children with a parent with cerebrovascular disease (CVD). Significant differences between controls and children in the other two groups were found for apolipoprotein A I, apolipoprotein B, and high density lipoprotein-cholesterol. Children of parents with CHD differed from controls in total cholesterol and apolipoprotein A II concentrations. A highly significant difference furthermore was found in lipoprotein (a) concentrations from children of parents with CHD in comparison with controls, but not between children of parents with CVD and controls. The difference in lipoprotein (a) concentrations (children of parents with CHD compared with controls) were only noticed in children above the age of 10 years. This could be explained by the observed rise of lipoprotein (a) between age 2 and 13 years, which was much more pronounced in the group with parents who had CHD. Plasma glycosaminoglycan concentrations were also measured in the three groups. They were significantly higher in children of parents with CHD and CVD compared with controls; they also varied with age.</description><subject>Adolescent</subject><subject>Age Factors</subject><subject>Apolipoprotein A-I - analysis</subject><subject>Apolipoprotein A-II - analysis</subject><subject>Apolipoproteins - blood</subject><subject>Apolipoproteins B - blood</subject><subject>Arteriosclerosis - blood</subject><subject>Arteriosclerosis - genetics</subject><subject>Biological and medical sciences</subject><subject>Cerebrovascular Disorders - blood</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Cholesterol, HDL - blood</subject><subject>Coronary Disease - blood</subject><subject>Glycosaminoglycans - blood</subject><subject>Humans</subject><subject>Lipoproteins, HDL - blood</subject><subject>Medical sciences</subject><subject>Metabolic diseases</subject><subject>Risk Factors</subject><issn>0003-9888</issn><issn>1468-2044</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkEtP3DAUhS3Uig6UJctKWSA0LDL4FcfeIKEB2kojUMVjwca6cWwwZOLBzlTw78koo6GsuvD14nw699yD0D7BE0KYOIbaTISYqAnBBd9CI8KFzCnm_AsaYYxZrqSU39BOSk8YEyol20bbRFFVEDpC5zO_CIsYOuvbbAxHmQmtsW0XofOhTRmkLPr0nPm29ga6EFPmQsyge7QxJNOspk_f0VcHTbJ7638X3V6c30x_5bOrn7-np7O84pJ2ubKOY6IUr4iTNecFYC5qS0EpRoUzgitglCjHK2YJKGmLqjKyxg5ofypju-hk8F0sq7mth6CNXkQ_h_imA3j9WWn9o34IfzUpFcOF6A0O1wYxvCxt6vTcJ2ObBloblkmXlAhOZdGD-QCa_sAUrdssIVivetd971oIrfSq957_8W-yD3ooutcP1jokA42L0BqfNljBSyb6t1nrU2dfNzLEZy1KVhb68m6qxT0nZ3fXf_Rq7Xjgq_nTfxK-A9wGqCg</recordid><startdate>19910901</startdate><enddate>19910901</enddate><creator>Kostner, G M</creator><creator>Czinner, A</creator><creator>Pfeiffer, K H</creator><creator>Bihari-Varga, M</creator><general>BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health</general><general>BMJ</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19910901</creationdate><title>Lipoprotein (a) concentrations as risk indicators for atherosclerosis</title><author>Kostner, G M ; Czinner, A ; Pfeiffer, K H ; Bihari-Varga, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b482t-9ef401994b1f8d445a046de2a99326fc649a3219f4b3e1a98e5bbc8d0fa213633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Adolescent</topic><topic>Age Factors</topic><topic>Apolipoprotein A-I - analysis</topic><topic>Apolipoprotein A-II - analysis</topic><topic>Apolipoproteins - blood</topic><topic>Apolipoproteins B - blood</topic><topic>Arteriosclerosis - blood</topic><topic>Arteriosclerosis - genetics</topic><topic>Biological and medical sciences</topic><topic>Cerebrovascular Disorders - blood</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Cholesterol, HDL - blood</topic><topic>Coronary Disease - blood</topic><topic>Glycosaminoglycans - blood</topic><topic>Humans</topic><topic>Lipoproteins, HDL - blood</topic><topic>Medical sciences</topic><topic>Metabolic diseases</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kostner, G M</creatorcontrib><creatorcontrib>Czinner, A</creatorcontrib><creatorcontrib>Pfeiffer, K H</creatorcontrib><creatorcontrib>Bihari-Varga, M</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Archives of disease in childhood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kostner, G M</au><au>Czinner, A</au><au>Pfeiffer, K H</au><au>Bihari-Varga, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lipoprotein (a) concentrations as risk indicators for atherosclerosis</atitle><jtitle>Archives of disease in childhood</jtitle><addtitle>Arch Dis Child</addtitle><date>1991-09-01</date><risdate>1991</risdate><volume>66</volume><issue>9</issue><spage>1054</spage><epage>1056</epage><pages>1054-1056</pages><issn>0003-9888</issn><eissn>1468-2044</eissn><coden>ADCHAK</coden><abstract>The plasma concentration of different lipoproteins were measured in 102 control children, in 42 children with a parent suffering from coronary heart disease (CHD), and in 50 children with a parent with cerebrovascular disease (CVD). Significant differences between controls and children in the other two groups were found for apolipoprotein A I, apolipoprotein B, and high density lipoprotein-cholesterol. Children of parents with CHD differed from controls in total cholesterol and apolipoprotein A II concentrations. A highly significant difference furthermore was found in lipoprotein (a) concentrations from children of parents with CHD in comparison with controls, but not between children of parents with CVD and controls. The difference in lipoprotein (a) concentrations (children of parents with CHD compared with controls) were only noticed in children above the age of 10 years. This could be explained by the observed rise of lipoprotein (a) between age 2 and 13 years, which was much more pronounced in the group with parents who had CHD. Plasma glycosaminoglycan concentrations were also measured in the three groups. They were significantly higher in children of parents with CHD and CVD compared with controls; they also varied with age.</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health</pub><pmid>1929512</pmid><doi>10.1136/adc.66.9.1054</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0003-9888 |
ispartof | Archives of disease in childhood, 1991-09, Vol.66 (9), p.1054-1056 |
issn | 0003-9888 1468-2044 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1793056 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection |
subjects | Adolescent Age Factors Apolipoprotein A-I - analysis Apolipoprotein A-II - analysis Apolipoproteins - blood Apolipoproteins B - blood Arteriosclerosis - blood Arteriosclerosis - genetics Biological and medical sciences Cerebrovascular Disorders - blood Child Child, Preschool Cholesterol, HDL - blood Coronary Disease - blood Glycosaminoglycans - blood Humans Lipoproteins, HDL - blood Medical sciences Metabolic diseases Risk Factors |
title | Lipoprotein (a) concentrations as risk indicators for atherosclerosis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T23%3A06%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lipoprotein%20(a)%20concentrations%20as%20risk%20indicators%20for%20atherosclerosis&rft.jtitle=Archives%20of%20disease%20in%20childhood&rft.au=Kostner,%20G%20M&rft.date=1991-09-01&rft.volume=66&rft.issue=9&rft.spage=1054&rft.epage=1056&rft.pages=1054-1056&rft.issn=0003-9888&rft.eissn=1468-2044&rft.coden=ADCHAK&rft_id=info:doi/10.1136/adc.66.9.1054&rft_dat=%3Cproquest_pubme%3E72164285%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72164285&rft_id=info:pmid/1929512&rfr_iscdi=true |